Arctic Vision: Clearside's partner, Arctic Vision completes enrollment in phase 3 trial of XIPERE in China to treat uveitic macular edema

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), announced that Arctic Vision, Clearside's partner, has